Literatur
- 1
Anderson C C, Matzinger P.
Immunity
or tolerance: opposite outcomes of microchimerism from skin grafts.
Nat
Med.
2001;
7
80-87
- 2
Anderson D, Billingham R E, Lampkin G H, Medawar P.
The
use of skin grafting to distinquish between monozygotic and dizygotic
twins in cattle.
Heredity.
1951;
5
379-397
- 3
Bean M A, Akiyama M, Kodera Y, Dupont B, Hansen J A.
Human
blood T lymphocytes that suppress the mixed leukocyte culture reactivity
of lymphocytes from HLA-B14 bearing individuals.
J Immunol.
1979;
123
1610-1614
- 4
Billingham R E, Brent L, Medawar P B.
Actively
acquired tolerance of foreign cells.
Nature.
1953;
172
603-608
- 5
Burlingham W.
Soluble
MHC immunregulation and tolerance: a progress report.
Hum
Immunol.
2000;
61
1316-1319
- 6
Burlingham W J, Grailer A P, Fechner J H. et al .
Microchimerism
linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy)
in a tolerant renal transplant recipient.
Transplantation.
1995;
59
1147-1155
- 7
Burlingham W J, Kusaka S, Chin L T. et al .
Focal infiltrates in kidney allografts:
developing a model for clinical transplant tolerance.
Graft.
1999;
2
253-260
- 8
Carrodeguas L, Orosz C G, Waldman W J, Sedmak D D, Adams P W, VanBuskirk A M.
Trans
vivo analysis of human delayed-type hypersensitivity reactivity.
Hum
Immunol.
1999;
60
640-651
- 9
de Bueger M, Bakker A, Van Rood J J, Van der Woude F, Goulmy E.
Tissue
distribution of human minor histocompatibility antigens. Ubiquitous
versus restricted tissue distribution indicates heterogeneity among
human cytotoxic T lymphocyte-defined non-MHC antigens.
J Immunol.
1992;
149
1788-1794
- 10
Devlin J, Doherty D, Thomson L, Wong T, Donaldson P, Portmann B, Williams R.
Defining
the outcome of immunosuppression withdrawal after liver transplantation.
Hepatology.
1998;
27
926-933
- 11
Dey B, Sykes M, Spitzer T R.
Outcomes
of recipients of both bone marrow and solid organ transplants. A
review.
Medicine (Baltimore).
1998;
77
355-369
- 12
Geissler F, Jankowska-Gan E, DeVito-Haynes L. et al .
Human liver allograft acceptance and the „tolerance
assay”: In vitro anti-donor T-cell reactivity shows hyporeactivity
to donor cells but, unlike DTH, fails to detect donor linked suppression.
Transplantation.
2001;
27
571-580
- 13
Geissler F, Jankowska-Gan E, Sollinger H. et al .
Immunoregulation in a tolerant liver transplant
recipient: donor class I HLA triggers linked suppression of DTH.
Transplantation.
2000;
69
172
(Suppl)
- 14
Gianello P, Fishbein J M, Sachs D H.
Tolerance to primarily vascularized allografts
in miniature swine.
Immunol Rev.
1993;
133
19-44
- 15
Hasek M.
Manifestation
of vegatative assimilation in adaptation of higher animals to foreign
antigens.
Czech Biol.
1954;
3
327-339
- 16
Hayry P.
Chronic
allograft rejection: an update (Review).
Clin Transplant.
1994;
8
160-161
- 17
Homann D, Holz A, Bot A. et
al .
Autoreactive CD4+ T cells protect from autoimmune
diabetes via bystander suppression using the IL-4/Stat6 pathway.
Immunity.
1999;
11
463-472
- 18
Jamil B, Nicholls K, Becker G J, Walker R G.
Impact of acute
rejection therapy on infections and malignancies in renal transplant
recipients.
Transplantation.
1999;
68
1597-1603
- 19
Josien R, Heslan M, Brouard S, Soulillou J P, Cuturi M C.
Critical requirement for graft passenger
leukocytes in allograft tolerance induced by donor blood transfusion.
Blood.
1998;
92
4539-4544
- 20
Kabelitz D.
Apoptosis,
graft rejection, and transplantation tolerance.
Transplantation.
1998;
65
869-875
- 21
Keunecke C, Rothenpieler U, Zanker B, Schneeberger H, Illner W D, Theodorakis J, Stangl M,
Land W.
Mycophenolate
mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free
immunosuppressive maintenance regimen in a selected group of kidney-transplanted
patients.
Transplant Proc.
2000;
32
6S-8S
- 22
Ko S, Deiwick A, Jager M D. et
al .
The functional relevance of passenger leukocytes
and microchimerism for heart allograft acceptance in the rat.
Nat
Med.
1999;
5
1292-1297
- 23
Kusaka S, Grailer A P, Fechner J H. et al .
Clonotype analysis
of human alloreactive T cells: a novel approach to studying peripheral
tolerance in a transplant recipient.
J Immunol.
2000;
164
2240-2247
- 24
Lassner D, Geissler F, Bosse S. et al .
Diagnosis and monitoring of acute cytomegalovirus
infection in peripheral blood of transplant recipients by nested
reverse transcriptase polymerase chain reaction (RT-PCR).
Transpl
Int.
2000;
13
366-371
- 25
Mazariegos G V, Reyes J, Marino I R, Demetris A J, Flynn B, Irish W, McMichael J,
Fung J J, Starzl T E.
Weaning of immunosuppression in liver transplant
recipients.
Transplantation.
1997;
63
243-249
- 26
Medawar P.
A
discussion of Immunological tolerance.
Proc Roy Soc.
1956;
146
1-8
- 27
O’Connell P J, Burlingham W J.
Donor-dendritic
cell persistence in allograft recipients in the absence of immunosuppression.
J
Leukoc Biol.
1999;
66
301-305
- 28
Owen R D.
Immunogenetic
consequences of vascular anastomoses between bovine twins.
Science.
1945;
102
400-404
- 29
Penn I.
Occurrence
of cancers in immunosuppressed organ transplant recipients.
Clin
Transpl.
1998;
147-158
- 30
Sharabi Y, Abraham V S, Sykes M, Sachs D H.
Mixed allogeneic
chimeras prepared by a non-myeloablative regimen: requirement for
chimerism to maintain tolerance.
Bone Marrow Transplant.
1992;
9
191-197
- 31
Starzl T E.
Cell
migration and chimerism - a unifying concept in transplantation - with
particular reference to HLA matching and tolerance induction.
Transplant
Proc.
1993;
25
8-12
- 32
Starzl T E, Demetris A J, Trucco M. et al .
Systemic chimerism in human female recipients
of male livers.
Lancet.
1992;
340
876-877
- 33
Steinmuller D.
Immunization
with skin isografts taken from tolerant mice.
Science.
1967;
158
127-129
- 34
Uehling D T, Hussey J L, Weinstein A B, Wank R, Bach F H.
Cessation of immunosuppression after renal
transplantation.
Surgery.
1976;
79
278-282
- 35
VanBuskirk A M, Burlingham W J, Jankowska-Gan E. et al .
Human allograft acceptance
is associated with immune regulation.
J Clin Invest.
2000;
106
145-155
- 36
VanBuskirk A M, Wakely M E, Sirak J H, Orosz C G.
Patterns
of allosensitization in allograft recipients: long-term cardiac
allograft acceptance is associated with active alloantibody production
in conjunction with active inhibition of alloreactive delayed-type
hypersensitivity.
Transplantation.
1998;
65
1115-1123
- 37
Vazquez M A.
Chronic
rejection of renal transplants: new clinical insights.
Am
J Med Sci.
2000;
320
43-58
- 38
Warren E H, Greenberg P D, Riddell S R.
Cytotoxic T-lymphocyte-defined human minor
histocompatibility antigens with a restricted tissue distribution.
Blood.
1998;
91
2197-2207
- 39
Wood K J, Sachs D H.
Chimerism and
transplantation tolerance: cause and effect.
Immunol Today.
1998;
17
584-587
- 40
Yasumura T, Kahan B D.
Prolongation
of rat kidney allografts by pretransplant administration of donor
antigen extract or whole blood transfusion combined with a short
course of cyclosporine.
Transplantation.
1983;
36
603-609
- 41
Zavazava N, Kabelitz D.
Alloreactivity and
apoptosis in graft rejection and transplantation tolerance.
J
Leukoc Biol.
2000;
68
167-174
Dr. Felix Geissler
Universität Leipzig, Klinik für
Abdominal-, Transplantations und Gefäßchirurgie
Liebigstraße 20a
04103 Leipzig
Phone: 0341/9717200
Fax: +49/341/9717209
Email: felix@medizin.uni-leipzig.de
